Approval · Notice of Compliance 5316 · 2004
THYMOGLOBULIN: Notice of Compliance 5316
Issued September 3, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5316
- Date
- September 3, 2004
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Immunosuppressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THYMOGLOBULIN | 02246805 | Marketed |
Medicinal ingredients
- ANTI-THYMOCYTE GLOBULIN (RABBIT) 25 MG per VIAL